Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China · Delayed Price · Currency is CNY 9.35
-0.05 (-0.53%)
Jun 9, 2026, 3:04 PM CST
SHE:002399 Market Cap
SHE:002399 has a market cap or net worth of 12.41 billion as of June 9, 2026. Its market cap has decreased by -15.54% in one year.
Market Cap
12.41B
Enterprise Value
12.22B
Revenue
5.42B
Ranking
n/a
PE Ratio
36.06
Stock Price
9.35
Market Cap Chart
Since May 6, 2010, SHE:002399's market cap has decreased from 70.09B to 12.41B, a decrease of -82.29%. That is a compound annual growth rate of -10.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 12.47B | -20.74% |
| Dec 31, 2025 | 15.73B | 11.19% |
| Dec 31, 2024 | 14.15B | -7.78% |
| Dec 29, 2023 | 15.34B | -10.21% |
| Dec 30, 2022 | 17.09B | -25.00% |
| Dec 31, 2021 | 22.79B | -3.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fujian Cosunter Pharmaceutical | 14.14B |
| Shenzhen Kangtai Biological Products | 13.31B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.98B |
| Guobang Pharma | 12.44B |
| Henan Lingrui Pharmaceutical | 12.25B |
| Shanghai Shyndec Pharmaceutical | 12.02B |
| Beijing Aosaikang Pharmaceutical | 11.99B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.98B |